Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract by Vigil, Patrick D. et al.
Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli
Predicts Successful Colonization of the Urinary Tract
Patrick D. Vigil,a Ann E. Stapleton,b James R. Johnson,c,d Thomas M. Hooton,e Andrew P. Hodges,a Yongqun He,a and
Harry L. T. Mobleya
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USAa; Department of Medicine, Division of Allergy and
Infectious Diseases, University of Washington, Seattle, Washington, USAb; VA Medical Center, Minneapolis, Minnesota, USAc; Department of Medicine, University of
Minnesota Medical School, Minneapolis, Minnesota, USAd; and Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, Florida, USAe
ABSTRACT Uropathogenic Escherichia coli (UPEC) strains, which cause the majority of uncomplicated urinary tract infections
(UTIs),carryauniqueassortmentofvirulenceorﬁtnessgenes.However,nosingledeﬁningsetofvirulenceorﬁtnessgeneshas
been found in all strains of UPEC, making the differentiation between UPEC and fecal commensal strains of E. coli difﬁcult
withouttheuseofanimalmodelsofinfectionorphylogeneticgrouping.Inthepresentstudy,weconsiderthreebroadcategories
ofvirulencefactorssimultaneouslytobetterdeﬁneacombinationofvirulencefactorsthatpredictssuccessintheurinarytract.
A total of 314 strains of E. coli, representing isolates from fecal samples, asymptomatic bacteriuria, complicated UTIs, and un-
complicatedbladderandkidneyinfections,wereassessedbymultiplexPCRforthepresenceof15virulenceorﬁtnessgenesen-
codingadhesins,toxins,andironacquisitionsystems.Theresultsconﬁrmpreviousreportsofgeneprevalenceamongisolates
fromdifferentclinicalsettingsandidentifyseveralnewpatternsofgeneassociations.Onegene, tosA,aputativerepeat-in-toxin
(RTX)homolog,ispresentin11%offecalstrainsbut25%ofurinaryisolates.Whereas tosA-positivestrainscarryanunusually
highnumber(11.2)ofthe15virulenceorﬁtnessgenes, tosA-negativestrainshaveanaverageofonly5.4virulenceorﬁtness
genes.ThepresenceoftosAwaspredictiveofsuccessfulcolonizationofamurinemodelofinfection,evenamongfecalisolates,
andcanbeusedasamarkerofpathogenicstrainsofUPECwithinadistinctsubsetoftheB2lineage.
IMPORTANCE Escherichia coli is the primary cause of urinary tract infections, the most common bacterial infection of humans.
Virulenceofauropathogenicstrainistypicallydeﬁnedbytheclinicalsourceoftheisolate,theabilitytocolonizethebladderand
kidneysinamurinemodel,thephylogeneticgroupofthebacterium,andvirulencegenecontent.Herewedescribeanovelsingle
gene, the repeat-in-toxin gene tosA, the presence of which predicts virulence of E. coli isolates regardless of source. Rapid identi-
ﬁcation of uropathogenic strains of E. coli may aid in the development of therapeutic and preventive therapies.
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T
he majority of urinary tract infections (UTIs) in otherwise
healthy individuals are caused by uropathogenic Escherichia
coli (UPEC) (1). This unique group of E. coli strains can reside in
the lower gastrointestinal tract of healthy adults (2, 3), but upon
entryintotheurinarytractcanascendtoandcolonizethebladder,
causing cystitis. The infection may be conﬁned to the bladder, or
bacteria may ascend the ureters to infect the kidneys causing pye-
lonephritis. In severe cases, bacteria can further disseminate
acrosstheproximaltubularepitheliumandcapillaryendothelium
to the bloodstream, causing bacteremia (4). A signiﬁcant propor-
tionofUTIsoccurinpatientswithnoknownabnormalitiesofthe
urinary tract, so-called “uncomplicated UTIs.” However, certain
host characteristics, such as the presence of an indwelling Foley
catheterorcongenitaldefectinurinarytractanatomy,areconsid-
ered complicating factors for UTI, and increase susceptibility to
this infection, as well as affecting diagnosis and management (5).
Finally, colonization of the bladder in high numbers
(105 CFU/ml of voided urine) may occur without eliciting
symptoms from the host, a condition known as asymptomatic
bacteriuria (ABU) (6).
Asaspecies,E.colidemonstratessigniﬁcantgenomeplasticity,
possessing a well-conserved core genome, as well as highly vari-
able and heterogeneous accessory genetic material apparently ac-
quired through multiple horizontal gene transfer events (7).
Among UPEC strains, individual mechanisms of pathogenesis
have been well characterized (8); however, no single ﬁxed set of
virulence factors has been observed in the majority of clinical iso-
lates. Unlike the intestinal pathogenic E. coli strains, distinct
pathotypesofUPEChaveyettobedeﬁned(9).Withoutadistinct
set of markers to differentiate UPEC from other types of E. coli,
most of our knowledge about this important human pathogen
comes from studying a few prototype strains. Determination of a
moreaccurateandreliablepathogenicsignatureforUPECamong
the other commensal and pathogenic E. coli strains in the gastro-
intestinal tract, the natural reservoir of UPEC (2, 3, 10), will be
invaluableforinvestigationsoftheepidemiologyofUPECorpub-
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on the natural diversity of UPEC.
To develop means to reliably differentiate UPEC from non-
UPEC, we tested E. coli isolates from fecal samples and speciﬁc
UTIsyndromesforthepresenceofspeciﬁcgenespreviouslychar-
acterized as UPEC virulence factors or suspected to play a role in
ﬁtness in the urinary tract, querying whether unique combina-
tions of these genes were enriched in UPEC isolates from distinct
clinical syndromes. A single gene, tosA, which encodes an in vivo-
inducedrepeat-in-toxin(RTX)familymember,wasidentiﬁedasa
candidate UPEC marker. We tested the hypothesis that the pres-
enceoftosAcorrectlypredictstheabilityofastraintosuccessfully
colonize the urinary tract. Finally, the possibility that tosA-
positivestrainsrepresentaphylogeneticallydistinctsubsetwithin
the overall E. coli population was examined by sequence analysis
of representative isolates identiﬁed in the study.
RESULTS
Prevalence of virulence and ﬁtness genes increases in strains
fromclinicalscenariosofincreasingseverity.Acollectionof314
strains of E. coli, representing isolates from fecal samples, ABU,
uncomplicated cystitis and pyelonephritis, and complicated UTIs
(Table 1), was assessed by multiplex PCR for the presence of 15
virulence or ﬁtness genes (Fig. 1A). The 15 genes, chosen to
broadly represent documented virulence and ﬁtness factors and
general mechanisms of pathogenesis, have been well character-
ized, with the exception of tosA (Table 2). These genes are catego-
rizedasencodingproteinsthat(i)mediateadherencetohostcells
(ﬁmA and papA), (ii) mediate acquisition of the essential micro-
nutrient iron (chuA, hma, iutA, iroN, fyuA, iha, and ireA), or (iii)
secrete proteins that elicit toxic effects on host cells (hlyA, cnf1,
tosA,sat,picU,andtsh).Elevenofthechosengenesresideonlarge
stretches of DNA within the genome of E. coli CFT073 known as
pathogenicity-associated islands (PAI) (11), predicted to be ac-
quired through horizontal gene transfer, while three of the genes
are widely dispersed around the genome of the prototypical pye-
lonephritisstrainCFT073(Fig.1B).cnf1isnotpresentinCFT073,
but it is prevalent in other strains.
Screeningofthe314clinicalandfecalE.coliisolatesforUPEC-
associated virulence or ﬁtness genes identiﬁed a wide range of
prevalence values for the 15 targeted virulence genes, in certain
instances with considerable variation according to source group.
The average percentage of strains that scored positive for a given
gene per isolate group is shown in Table 2.
tosAisamarkerforthepresenceofothervirulenceorﬁtness
genes. In a previous study, our group identiﬁed tosA as the main
contributing factor of PAICFT073-aspV to enhanced ﬁtness of
UPEC strain CFT073 in a murine model of ascending UTIs (12).
Here, we explored associations among tosA and other virulence
genes by comparing the prevalence of other virulence genes in
isolates positive versus negative for a given virulence gene (Ta-
ble3).Inthisanalysis,tosA-positivestrainsoverallshowedacom-
bination of carrying the highest number of other virulence genes,
the greatest differential in overall virulence gene content, the
greatest differential in percent virulence gene prevalence, and the
ability of strains from a fecal source marked by that gene to colo-
nize both the murine bladder and kidney (Table 3), and thus, the
following analysis focused on this gene.
tosA-positiveisolatescollectivelyexhibitedahigherprevalence
of almost every virulence gene than was observed in any of the
clinical isolate groups (Tables 2 and 3). For example, hlyA was
present in 48% of pyelonephritis isolates (the highest-prevalence
clinicalgroup)butinfully70%oftosA-positiveisolates.Likewise,
the heme receptor chuA was present in 89.6% of pyelonephritis
TABLE 1 E. coli isolates used in this study
Clinical group No. of isolatesa Source of collectiona
Fecal 91 13, 35
Compromised host 41 38, 39
Asymptomatic bacteriuria 68 6, 35
Cystitis 37 25, 35, 36
Pyelonephritis 78 35, 37
a The number of total isolates of each category is given along with the reference to the
publication that describes the source of the isolates.
FIG 1 Virulence and ﬁtness genes assessed in this study. (A) Multiplex PCR
results using genomic DNA puriﬁed from CFT073, UTI89, and MG1655.
Primers speciﬁc for each virulence or ﬁtness gene were used for PCR ampliﬁ-
cation of gene fragments from a boiled lysate of the indicated E. coli strain. If
there was no band observed at the expected size, the result was counted as
negativeforthepresenceofagene().NT,no-templatecontrolsamples;Std,
DNA ladder standards. (B) Schematic of CFT073 genome with the location of
each gene under study indicated. The origin of replication is indicated by ori.
Previously identiﬁed pathogenicity-associated islands (PAI) or genomic is-
lands (GI) containing one or more genes under study are indicated according
to the nomenclature of Lloyd et al. (11). cnf1, which is not present in strain
CFT073, is not shown. Phage insertion sites (). Three genes, tsh, chu, and
ﬁmA, are not found in a PAI or GI.
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98.4% of tosA-positive isolates. tosA-positive isolates contained,
on average, 11.2 of the 15 studied virulence or ﬁtness genes,
whereas tosA-negative isolates averaged only 5.4 virulence or ﬁt-
ness genes (Table 3). This trend was observed regardless of from
which strain collection the tosA-positive isolate originated. When
data were analyzed independently in this way for every virulence
gene, strains grouped ﬁrst by tosA or second by picU were associ-
ated with the highest number of other virulence genes assayed for
inthisstudy(Table3).BothtosAandpicUgenesresidewithinthe
same pathogenicity-associated island, PAICFT073-aspV (Fig. 1B),
andthusmaybegeneticallylinkedinstrainswithinthecollection.
Other toxin genes. The category of secreted toxins showed a
similar pattern, with the prevalence of a given gene generally in-
creasing in relation to increasing clinical severity of the source
group. The ABU isolates were a notable exception. Although by
deﬁnition, ABU strains elicit no symptoms from the host, the
prevalenceofthegenesequencesinthiscategorywerecomparable
among ABU strains to those observed among cystitis and pyelo-
nephritis isolates. In the case of cnf1 (cytotoxic necrotizing factor
1), for example, ABU isolates were the highest-prevalence group.
However, the presence of a speciﬁc gene sequence does not nec-
essarilyindicatethepresenceofanintactgeneandfunctionalgene
product. Accordingly, additional experiments were conducted to
determine if multiplex PCR results for another toxin gene, hlyA,
whichencodedthesecretedtoxin-hemolysin,werepredictiveof
its distinctive phenotype.
ThepresenceorabsenceofthesecretedproteintoxingenehlyA
among strains in this study is highly correlated with the in vitro
hemolysisphenotype.Whenthe314strainsunderstudywerecul-
tured on 5% sheep blood agar plates, a positive PCR result pre-
dictedahemolyticpatternonbloodagarplateswithasensitivityof
97.9%. A negative PCR result for this gene was determined to be
98.1% speciﬁc for a lack of hemolysis seen on blood agar plates.
Previousresearchhasestablishedthatthepresenceofhemolysinis
predictive of the level of pathology observed in tissue culture sys-
tems (13) and correlated to the severity of pathology observed in
the murine model of an ascending UTI (14). The high sensitivity
TABLE 2 Prevalence of virulence-associated genes among E. coli isolates from different clinical settings
Isolate type
% of isolates with genea
Adhesins Toxins Outer membrane iron receptors
ﬁmA papA hlyA cnf1 tosA sat pic tsh chuA hma iutA iroN fyuA iha ireA
Fecal 98.9 26.4 13.2 7.7 11.0 19.8 12.1 20.9 39.6 26.4 31.9 20.9 47.3 31.9 14.3
CHb 97.6 51.2 19.5 4.9 19.5 41.5 12.2 48.8 75.6 34.1 58.5 26.8 78.0 46.3 24.4
ABUc 98.5 54.4 35.3 33.8 26.5 33.8 23.5 63.2 73.5 51.5 45.6 41.2 83.8 35.3 16.2
Cystitis 97.3 67.6 48.6 32.4 16.2 32.4 18.9 54.1 83.8 81.1 43.2 48.6 89.2 37.8 10.8
Pyelonephritis 98.7 63.6 48.1 13.0 28.6 51.9 29.9 67.5 89.6 61.0 66.2 41.6 93.5 55.8 27.3
tosA-positive strains 98.4 59.4 70.3 37.5 100.0 67.2 89.1 96.9 98.4 92.2 67.2 59.4 98.4 67.2 20.3
tosA-negative strains 98.4 47.2 21.6 12.0 0.0 26.8 2.0 36.8 61.6 36.4 43.2 28.0 69.6 34.4 18.4
a Gene prevalence is expressed as the percentage of isolates that scored on multiplex PCR.
b CH, compromised host anatomy.
c ABU, asymptomatic bacteriuria isolates.
TABLE 3 Characteristics of isolates marked by the presence of a single virulence or ﬁtness gene
Gene
Avg no. of virulence genes present
in isolatea
VFb
Avg % change
in gene prevalencec
t test result ford:
Positive Negative Bladder Kidney
tosA 11.2 5.4 5.9 34.7 0.0001 0.0071
picU 11.2 5.4 5.8 34.6 0.0001 NS
hlyA 10.1 4.9 5.2 30.2 NS NS
cnf1 10.1 5.8 4.3 23.7 NS NS
sat 9.5 5.0 4.5 25.2 NS NS
hma 9.4 4.0 5.4 31.6 0.0001 0.0074
tsh 9.4 3.9 5.5 32.1 0.0001 NS
iroN 9.0 5.3 3.7 19.5 NS NS
iha 9.0 4.9 4.1 22.1 NS NS
papA 9.0 4.2 4.8 26.9 0.014 NS
ireA 8.7 6.1 2.7 11.8 0.0002e 0.0155e
iutA 8.7 4.6 4.1 22.1 0.0405e NS
chuA 8.4 2.4 6.0 35.4 0.0003 NS
fyuA 8.1 1.7 6.4 38.6 0.0017 NS
ﬁmA 6.6 6.6 0.0 7.5
a Average number of the 15 virulence factors present in isolates that contain (positive) or lack (negative) the indicated gene.
b VF, difference in the number of virulence factors between positive and negative.
c The percentage change in gene prevalence of all 15 genes is averaged for each group.
d Data in Fig. 2B and C were grouped according to the presence or absence of each gene and reanalyzed; the P value of each group that was found to be signiﬁcant is reported. NS,
not signiﬁcant.
e These genes were found to be negatively correlated with CFU/g of tissue. The presence of ireA was found previously (44) to negatively correlate with lethality in a murine model of
peritonitis.
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molysinphenotypeindicatedthatthedataonagene’spresenceor
absence provided insight into the pathogenic potential of each
strain. This appealing concept was further investigated with sev-
eral statistical tools in an analysis of the entire data set to gain a
more detailed understanding of how the molecular mechanisms
of pathogenesis are distributed among natural isolates of E. coli
(see the section on testing of three models).
Adhesinandironacquisitiongenes.ﬁmAencodingthetype1
ﬁmbriamajorstructuralsubunitwasalmostuniversallypresentin
strains from each clinical group regardless of source, with 98%
ofisolatestestingpositive.Incontrast,papA(codingforthestruc-
tural subunit of pyelonephritis-associated pili), although less
prevalent overall (56.5%), was signiﬁcantly more prevalent
among all urine isolates combined (59.2%) than among fecal iso-
lates (26.4%) (P  0.0001). Both of these ﬁndings are in general
agreement with results from previous studies (4).
The genes encoding outer membrane iron receptors (chuA,
hma, iutA, iroN, fyuA, iha, and ireA) were less common among
fecal isolates (average prevalence, 30.3%; range, 14.3 to 47.3%)
and more common among strains isolated from a symptomatic
UTI (average prevalence of 59.3% and range of 10.8 to 93.5%),
with the prevalence rates of certain genes, such as fyuA in pyelo-
nephritis isolates, exceeding 90%. This result is also in agreement
with previously published ﬁndings (15).
tosA-positive strains colonize the murine urinary tract re-
gardless of clinical source. If one hypothesized that the presence
of tosA predicts virulence regardless of clinical source, then the
presence of tosA should predict successful colonization of a tosA-
positive fecal E. coli isolate in the murine model of an ascending
urinary tract infection. For example, EFC5, a fecal isolate from a
healthy human volunteer (13) determined in this study to be tosA
positive,wastransurethrallyinoculatedintothebladderoffemale
C57BL/6 mice. Forty-eight hours postinoculation, mice were eu-
thanized, bladder and kidney tissue was removed, and the CFU/g
of tissue was determined for each mouse to assess whether or not
this fecal isolate could colonize and survive in the host’s urinary
tract. This was repeated with strain CFT073, a human pyelone-
phritis isolate that is also tosA positive (Fig. 2A). There were no
differences observed among colonization levels for both bladder
and kidney tissue between these two strains, indicating that the
fecalisolateEFC5wasasuccessfulcolonizerinthismodelsystem.
The murine model is recognized as capable of differentiating
fecal and uropathogenic strains of E. coli (13, 16). However, fecal
E.coliisolatesthatcarrytosAcolonizethemurinemodelinhigher
numbers in both bladder and kidney tissue than tosA-negative
fecal isolates. Seven tosA-positive fecal strains, including EFC5,
were tested in the murine model and compared to 10 tosA-
negative fecal isolates for CFU/g of bladder (Fig. 2B) or kidney
tissue (Fig. 2C) at 48 h postinfection. Statistically signiﬁcant dif-
ferences were observed using a two-tailed Student’s t test with
higher average CFU levels in the tosA-positive group for both
bladder (P  0.001) and kidney (P  0.01) tissue.
ThepresenceoftosAalsopredictedagreaterCFUloadinblad-
derandkidneytissueofinfectedmiceregardlessofthehostspecies
from which a strain was isolated. One tosA-positive strain (ECOR
57)andonetosA-negativestrain(ECOR70)isolatedfromgorillas
were compared for the ability to colonize in the murine model
describedabove.AsecondpairoftosA-positiveandtosA-negative
fecal isolates from orangutans (ECOR 52 and ECOR 7) was also
A
B
C
FIG 2 tosA presence predicts successful colonization of the murine urinary
tract.(A)Miceweretransurethrallyinoculatedwith108CFUofeitherCFT073
or EFC5. Forty-eight hours postinoculation, bladders and kidneys were re-
moved, and the numbers of CFU/g of tissue were determined. Each dot rep-
resentstheCFUloadforonemouse.PanelsBandCshowcombinedresultsfor
10 tosA-negative and 7 tosA-positive strains for bladder and kidney tissue,
respectively. Each dot represents one mouse (n  44 and 48 for tosA-positive
and tosA-negative, respectively).
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kidney,whileonlyECOR7,atosA-negativestrainisolatedfroman
orangutan, colonized the bladder and kidneys (data not shown).
An additional tosA-positive fecal isolate collected from a lion
(ECOR 58) was tested and found to colonize both bladder and
kidneys in the murine model. ECOR 58 is unusual as this strain
only contained three additional genes tested for in this study
(ﬁmA, picU, and iroN). These results demonstrate that the tosA
gene is a marker for strains that can successfully colonize the mu-
rine model, including fecal E. coli isolates from other animals as
well as for isolates that contained relatively few of the genes that
have been well studied in the context of pathogenesis in the uri-
nary tract.
tosA-positivestrainscompriseadistinctsubsetoftheB2lin-
eageofE.coli.Amultiplexassay(17)toplaceE.coliintooneofthe
fourmainECORphylogeneticgroupassignments,A,B1,B2,orD,
was applied to each strain in this study (Table 3). E. coli fecal
isolateswerefrequentlyplacedwithingroupA(42.9%ofisolates),
butthisgrouplesscommonlycontainedisolatesculturedfromthe
urinarytract.Forexample,only7.7%ofstrainsisolatedfromcases
ofpyelonephritislocalizedtogroupA.Ontheotherhand,70%of
isolates from cases of cystitis and pyelonephritis were found to be
membersofgroupB2,whichwasthemostcommongroupamong
isolates from the urinary tract. In contrast to this, 63 of the 64
(98.4%) tosA-positive strains in this study were determined to
reside in the B2 phylogenetic group of E. coli. A single tosA-
positiveisolate(ECOR58)localizedtotheB1phylogeneticgroup.
Thehypothesisthattheseisolatescomprisedacloselyrelatedsub-
set of UPEC was then examined further by sequence analysis
The majority of tosA-positive isolates (8 of 12 [66.6%]) exam-
ined by multilocus sequence typing (MLST) belonged to a single
sequence type (ST) complex, ST complex 73. In addition to the
ECORstraincollection,thestrainsexaminedinthemurinemodel
were assigned to a ST by standard protocols (18), and this collec-
tion of sequences was used to build a dendrogram illustrating the
relationship of these groups to each other (Fig. 3). The ECOR
strain collection provided a framework of sequence types associ-
atedwitheachofthefourmainE.coligroupsaswellasasourceof
severalgroupsofE.colipreviouslydeterminedtohaveundergone
extensive genetic recombination. The only isolate that contained
tosA outside of the B2 group (ECOR 58) was previously deter-
mined to belong to a group of E. coli strains that appear to have
undergone extensive recombination with other groups of E. coli
(18). Further examination of the MLST database showed that the
majorityofstrainsinSTcomplex73(29of48[60.4%])areUPEC
isolates and were collected in the setting of a human UTI (18).
BasedontheMLSTandECORtyping,tosAappearstobeamarker
for a group of strains that are enriched for UPEC and present in a
few outlier groups that may have acquired this gene by extensive
genetic recombination.
Testing of three models for assessing pathogenic potential.
While we have discovered that the presence of tosA predicts viru-
lenceregardlessofclinicalsource,canwealsousethefullvirulence
andﬁtnessgeneprevalencedatasettodifferentiatestrainsbyclin-
ical source alone? Fecal isolates of E. coli on average had signiﬁ-
cantly fewer virulence genes (mean of 4.2) than isolates from the
urinarytract(meanof7.5)(Table4).Onesimplemodelthatcould
explain the difference in the distribution of the genes under study
is that isolates that caused the most severe clinical disease contain
more genes and mechanisms linked to pathogenesis than those
that cause milder clinical cases of disease or those that were ob-
tainedfromhealthyindividuals.Thismodelwastestedbyaverag-
ing the number of genes detected as present in a group of strains
and compared across all groups by one-way analysis of variance
(ANOVA) (Fig. 4A). The global test statistic was signiﬁcant (P 
0.001);however,pairwisetestingwasonlysigniﬁcantforfecaliso-
lates compared to the other groups and for comparison of pyelo-
nephritis isolates with isolates from patients with compromised
urinary tract anatomy. This indicates that fecal isolates can be
differentiatedfromstrainsofE.coliisolatedfromtheurinarytract
based on the average number of virulence-associated genes pres-
ent, but that this is insufﬁcient to fully differentiate between uri-
nary tract isolates from speciﬁc clinical scenarios of different se-
verities. Isolates that were presumed to have limited pathogenic
potential, such as ABU isolates, were indistinguishable from iso-
lates known to be highly pathogenic and elicit strong symptoms
from the host, such as pyelonephritis isolates, based on this test.
While it is possible that ABU isolates are true pathogens and the
lackofsymptomsistheresultofhostinnateimmunedefectsinthe
FIG3 PhylogeneticrelationshipoftosA-positivestrains.RepresentativetosA-
positive strains included in this study are marked with stars. The four main
groupsofE.coli(A,B1,B2,andD)andtwogroupsofrecombinants(ABDand
AxB1)wereassignedaccordingtoWirthetal.(18).MLSTcomplexes73and14
are indicated next to representative isolates from each group. Sequences from
Escherichia clade 1 isolates that do not group with phylogenetic groups A, B1,
and B2 (D) or the hybrid groups AxB and ABD were used to root the dendro-
gram (42).
Presence of tosA Predicts Virulence of UPEC
May/June 2011 Volume 2 Issue 3 e00066-11
® mbio.asm.org 5infected individual (19), it is also possible that mutations exist
within virulence gene operons, rendering their products inactive
(20).
A second model that could explain the distribution of the ge-
netic mechanisms of virulence, based on classes of virulence de-
terminants present in the urinary tract, was explored. UPEC
strains are genetically heterogeneous and often exhibit multiple
molecular mechanisms for causing disease, such as secreting a
series of protein toxins (8) or synthesizing multiple acquisition
systems for the uptake of iron and iron-containing compounds
(15). The second model assumed that success in the urinary tract
andtheproductionofsymptomsinthehostwerethesumofthree
activities—theproductionoflargesecretedproteintoxinsorRTX
family member (cnf1, hlyA, and tosA), the production of secreted
proteolytic autotransporter proteins (sat, pic, and tsh), and the
acquisition of iron (chuA, hma, iutA, iroN, fyuA, iha, and ireA).
Under this model, the isolates from different clinical groups may
be differentiated by comparing the potential of the strains to
achieve each of these three activities. After averaging the number
ofgenesineachcategoryperstrainandadjustingforthemeanand
standard deviation of each category, a multivariate version of an
ANOVAdesign(MANOVA)wasusedtoseekdifferencesbetween
the clinical groupings. Similar to the ﬁrst model, although the
globaltestwassigniﬁcant(P0.001),pairwisetestingonlyclearly
differentiated fecal isolates from the other clinical isolates. The
urine-source groups were statistically indistinguishable, regard-
less of disease severity or host compromise status.
The third model, which was able to differentiate between
groups of urinary tract isolates, assumed that each genetic mech-
anism of survival and pathogenesis (deﬁned by the presence of
distinct virulence or ﬁtness genes) confers a unique advantage in
thehost.Underthismodel,thelevelofsuccessofastrainofE.coli
in different patient populations and sites within the urinary tract
would be partly determined by the unique contribution of each
genetic mechanism of pathogenesis. While this study could not
assesstheentirecollectionofknownvirulencefactorsdescribedin
the literature, the 15 genes assayed by PCR provided sufﬁcient
information to allow a multivariate ANOVA model using the full
presence or absence data for each gene to test for differences in
geneprevalenceratesbetweenallﬁvegroupsofisolates.Similarto
the ﬁrst two models, the global test was signiﬁcant (P  0.001),
and fecal isolates were signiﬁcantly different from other strain
collections. However, signiﬁcant differences were also observed
among E. coli isolates from patients with different clinical scenar-
ios. Under this model, all groups of urinary tract isolates were
distinguishedfromeachother,exceptforanoverlapbetweenABU
isolatesandisolatesfrompatientswithcompromisedurinarytract
anatomyandbetweenABUisolatesandcystitisisolates.Figure4B
presents a visual representation of the results of the ANOVA and
MANOVAtestinganddemonstratesthat,evenafterallowingeach
ofthe15genesstudiedtocountasseparatevariables,urinarytract
isolates of E. coli from the four different classes of clinical severity
exhibited more similarities to other urinary tract isolates than to
fecal isolates.
tosA-positive isolates are signiﬁcantly different from tosA-
negative strains in all three statistical models tested. Due to the
high similarity noted among the gene prevalence data, the three
models described above were retested with the strains grouped by
the presence or absence of tosA. Because only two groups (tosA
positiveandtosAnegative)werebeingtested,theoriginalANOVA
was replaced by a Student’s t test for evaluation of the average
number of genes present. Both multivariate tests were conducted
asbefore,andineachcase,tosA-positiveisolatesweresigniﬁcantly
different from tosA-negative isolates (P  0.01).
Bayesian network modeling reveals extensive connections
betweenvirulenceandﬁtnessgenes.Finally,toseekrelationships
between the combinations of virulence genes present in speciﬁc
strains, Bayesian network (BN) modeling was employed. This
technique allows the inﬂuence of the presence of a gene on the
presenceoftheothergenestobeassessedvisuallywithouttheneed
for hundreds of individual pairwise statistical comparisons. A
consensus network compiled from the best scoring models dis-
covered numerous connections between genes (Fig. 4C). For ex-
ample, three genes, tosA, tsh, and iroN, are at the top of the hier-
archical structure within the consensus network. These genes
appear to inﬂuence or closely associate with the presence or ab-
sence of the other genes. This model illustrates that only the yers-
iniabactin receptor (fyuA) was directly linked to a particular clin-
icalsetting(“group”).Indeed,fyuAislesscommoninfecalisolates
(47.3%) but steadily increases in presence as the severity of the
disease increases, reaching a maximum prevalence of 93.5% in
pyelonephritis isolates (Table 2). Our model also indicates that
fyuA is closely associated with and possibly inﬂuenced by three
other genes: tsh, papA, and iutA. Table 2 indicates that these three
geneshaveasimilarpatterntofyuA.However,basedontheavail-
able binary data, our modeling predicted that fyuA has strong
direct association with the clinical setting.
DISCUSSION
Virulence-associated gene content among E. coli isolates from the
urinary tract demonstrated more similarities to other UPEC
strains than to fecal isolates. While a general trend of increasing
numbers of virulence factors was observed in strains obtained
from the more severe clinical settings (Table 4 and Fig. 4A), each
TABLE 4 Average number of virulence-associated genes and ECOR group membership
Clinical group
Avg no.
of virulence genes
% of isolates that belong to ECOR phylogenetic groupa:
A B 1B 2D
Fecal 4.2 42.9 18.7 20.9 17.6
Compromised host 6.4 17.1 7.3 51.2 24.4
Asymptomatic bacteriuria 7.2 15.9 11.1 58.7 14.3
Cystitis 7.6 16.7 0.0 71.4 11.9
Pyelonephritis 8.4 7.7 2.6 70.5 19.2
tosA-positive strains 11.2 0.0 1.6 98.4 0.0
tosA-negative strains 5.4 27.6 11.2 39.2 22.0
a ECOR group membership expressed as % of isolates that belong to the four main ECOR phylogenetic groups.
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ysis of the entire virulence gene prevalence data set (Fig. 4B). In
contrast, strains that carried tosA were easily differentiated from
tosA-negative strains by several measures. tosA, a putative RTX
familymembergene(12),co-occurredonaveragewithmorethan
10 of the other 14 genes assayed for in this study, and thus its
presencewaspredictiveofhighlyvirulentstrains(Tables2and3).
This gene represents a marker for E. coli belonging to the B2 phy-
logenetic group and is enriched in sequence type complex 73, a
group of E. coli strains enriched for UPEC isolates, including the
prototype human pyelonephritis strain CFT073 (18) (Fig. 3).
UPEC strains reside in the gastrointestinal tract and thus can
occasionally be isolated among commensal strains cultured from
fecal samples (2, 3, 21). Indeed, the presence of tosA predicted
successful colonization of all but one of seven tosA-positive fecal
E. coli isolates tested in the murine model of an ascending UTI
(Fig. 2B and C). ECOR 51, the only tosA-positive fecal isolate that
did not colonize the animal model, lacked the gene ﬁmA, the ma-
jorstructuralsubunitoftype1ﬁmbriae.Whiletype1ﬁmbriaeare
critical for the success of UPEC in the murine model (22–24),
recent studies have questioned the importance of this factor in
humaninfections(25,26)andraisethepossibilitythatthisisolate
could potentially colonize the human urinary tract. While it was
beyond the scope of this study to identify a speciﬁc role for this
gene in bacterial pathogenesis, the results presented here indicate
that success of tosA-positive strains may rely in part on the co-
occurrence of known virulence factors of UPEC. With the excep-
tionofpapAandireA,thehighestprevalenceofthe12othergenes
included in this study among all groups of isolates was observed
among tosA-positive strains (Table 2). However, the observation
that ECOR 58, a fecal E. coli isolate that lacked many of the best-
characterizedUPECvirulencefactors,demonstratesthattosAcan
nevertheless serve as a marker both for UPEC strains that are
predicted to cause disease through well-known mechanisms as
well as for strains that may contain unique and as yet uncharac-
terized approaches to colonizing the host urinary tract.
One goal of the study was to determine whether we could dif-
ferentiatestrainsbasedonclinicalsourceandvirulenceandﬁtness
gene content. First, it was straightforward to statistically separate
fecal strains from strains isolated from the urinary tract by using
the three models (Fig. 4). However, separation of isolates by spe-
ciﬁc clinical populations proved more difﬁcult. We found seem-
ingly minimal differences in the numbers of virulence or ﬁtness
genes among UPEC isolates from different patient populations
(Fig. 4A). Using model 3, however, these differences were sufﬁ-
cient to differentiate between strains from patients with compli-
cated UTI (compromised host urinary tract anatomy) and those
from uncomplicated symptomatic infections (cystitis and pyelo-
nephritis) (Fig. 4B).
ABU strains in this study, on the other hand, failed to coalesce
into a discrete group and instead revealed a spectrum of isolates
that ranged from strains that contained only 1 of the 15 genes
assayed to strains that contained 14 of the same genes (Fig. 4A).
These strains, by our analysis, closely resemble fecal commensal
strains that failed to colonize the murine model (that is, with low
virulence potential) and those strains that more closely resemble
human cystitis isolates (with higher virulence potential), respec-
tively.Thatthesestrainscolonizebutelicitnosymptomscouldbe
explained in at least three ways. (i) Low-virulence strains, unre-
lated to typical UPEC strains, could colonize a healthy individual
if there were additional as yet undetermined colonization genes
present (27, 28). Lack of virulence factors would not damage the
hostandthuscausenosymptoms.(ii)Strainswithahighnumber
ofvirulencegenescouldcontainmutationswithinthesegenesthat
A
B
C
FIG 4 Models demonstrating differences and similarities between E. coli
isolates from different clinical settings. (A) Under the ﬁrst model, groups are
placed according to the average number of virulence factors as described in a
box-and-whiskerplotinwhichthemeanisindicatedbyaverticalline,the25th
and 75th percentiles are indicated by the left and right borders of the box, and
the 10th and 90th percentiles are indicated by the whiskers. Dots represent
outliers in the analysis. (B) The third model used multivariate ANOVA of the
full presence or absence data for each gene to test for differences in gene
prevalence rates between all ﬁve groups of isolates. Groups shown to overlap
cannotbereadilydifferentiatedbasedonthedatacollectedinthisstudy,while
those that do not overlap were found to contain different combinations of the
genes under study. (C) Bayesian model of unique connections between viru-
lence and ﬁtness factor genes. The presence or absence of each gene in each of
314 strains was modeled to identify a consensus network of the genes. Knowl-
edgeofthepresenceorabsenceofagivengenepredictsthepresenceorabsence
of another gene. Arrows indicate directed edges linking two variables together
in the network.
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strain 83972, for example, may represent such a strain that con-
tains virulence genes but also carries mutations within some of
these genes (20, 29). (iii) Truly high-virulence strains with intact
virulence genes could colonize a host with defects in innate im-
munitywhocannotrespondproperlytoinfection(19).Thebroad
overlap of ABU isolates with strains obtained from hosts with
compromised urinary tract anatomy and the overlap with cystitis
isolates observed in this study could be explained by a combina-
tion of these three scenarios.
Bayesian network analysis is a powerful statistical method that
infers potential relationships among a set of variables and pro-
vides an alternative to analyzing hundreds of individual pairwise
comparisons (30, 31). In the present study, such a network indi-
catesthattheknowledgeofthepresenceorabsenceofagivengene
can predict the presence or absence of another gene. Before con-
ducting this analysis, we predicted that genes contained in the
same pathogenicity-associated island (PAI), large stretches of
DNA thought to be acquired en masse through horizontal gene
transfer, would be linked together in the consensus network
(Fig. 4C). For example, PAICFT073-pheV contains papA, sat, iha,
iutA, and hlyA; these genes are all serially connected in the con-
sensusnetwork.Whatwasnotexpectedwasthatnearlyeverygene
includedinthestudywoulddemonstratesomelevelofconnectiv-
ity.Asanexample,thegenetsh,whichencodesanautotransporter
expressedduringbothinvivoandinvitrogrowthofCFT073(32),
is not associated with any known PAI (Fig. 1B). Despite this, tsh
contains direct links to 8 other genes in the consensus network.
This result indicates that gene association between established
UPEC virulence factors may not be conﬁned to those genes con-
tainedinthesamePAI.Inaddition,thegenecontentofaPAI,the
location of additional copies of the same genes outside of the ar-
chetypal PAI, and differences in number of PAIs have been previ-
ouslydocumentedbetweenstrainsofUPEC(7,33).TheBayesian
network results (Fig. 4C) are consistent with the hypothesis that
such genetic reassortments of virulence factors are common
among UPEC strains.
Given the previous observations that Bayesian network analy-
sis is sufﬁciently robust to screen out noise in large gene expres-
sion arrays (30, 34), it is surprising that only the yersiniabactin
receptor gene fyuA, and not tosA or other genes, was determined
to directly inﬂuence the probability that a given strain originated
inaparticularclinicalgroup.Indeed,ourBayesiannetworkmod-
eling found that the presence or absence of fyuA was directly as-
sociated with or inﬂuenced by three other genes (tsh, papA, and
iutA), and the presence of tosA appears to play a leading role in
predicting the presence of many of the other genes (Fig. 4C). This
wassomewhatsurprisingsincetosAwasfoundinonlyone-fourth
of strains. Taken together, these results may suggest that distinct
pathotypes of UPEC exist, but identiﬁcation of these groups will
requireknowledgeaboutthediversemechanismsofpathogenesis
found within each of the different subpopulations of UPEC.
WedeﬁneaUPECstrainasonethatinfectsthehumanurinary
tract. Our tools to deﬁne such an isolate include virulence and
ﬁtnessgenecontent,colonizationofthemurineurinarytract,and
the original clinical source. We observed here that clinical source
alone is not necessarily predictive of UPEC status, nor is the pres-
ence of a single gene. Not all isolates that have the potential to
colonize the urinary tract, for example, carry the tosA gene. Only
24.3% (28/115) of cystitis and pyelonephritis isolates, in the pres-
ent study, contain this gene. These isolates are most likely to re-
sembleSTcomplex73strainssuchasCFT073,butothergroupsof
UPECexist.StrainssuchasE.colifecalcontrol24(EFC24),oneof
the tosA-negative strains investigated in this study that success-
fully colonized the bladders of infected mice, represent one of the
groups that together comprise the remaining 75% of UPEC iso-
lates.EFC24wasdeterminedinthisstudytobelongtoSTcomplex
14, a group of B2 isolates highly enriched for UPEC. In fact, 10 of
the 13 (76.9%) isolates that make up ST complex 14 were isolated
from the human urinary tract (18). While many of the tosA-
negative fecal strains that were successful in the murine model
appeartobelongtolargergroupsofurinarytractisolates,noneof
the genes included in this study could differentiate these isolates
from those tosA-negative isolates that failed to colonize the host
urinary tract. Additional studies will be necessary to identify a
reliable marker for groups of UPEC that lack the tosA gene.
Despite these limitations, the presence or absence of tosA pro-
videsusefulinformationinassessingthepathogenicpotentialofa
given E. coli isolate. As this gene is found in one-quarter of UPEC
strainsthatcausesymptomaticinfectionsinnormalhumanhosts,
assaying for this one gene would enable larger studies that have
previously not been feasible, such as studies that compare UPEC
carriageratesinpatientpopulationswithdifferentratesofurinary
tract infections. When combined with other virulence and ﬁtness
genes such as hma, picU, and fyuA, the urovirulence potential of
these isolates could be accurately predicted. Given the heteroge-
neity in pathogenetic mechanisms observed among UPEC, such
an understanding may prove critical to future efforts to develop
novel therapeutic strategies to combat this widespread human
pathogen.
MATERIALS AND METHODS
Strain collection and culture conditions. A total of 314 strains of E. coli
was collected from a variety of clinical settings (Table 1) (6, 13, 20, 25,
35–39). The collection covered a range of natural isolates, from non-
pathogenic strains that reside in the lower gastrointestinal tract to highly
pathogenic strains that were isolated from the blood of human patients
with clinical cases of pyelonephritis complicated by bacteremia. This col-
lection included a broad range of human fecal isolates and isolates from
nonhuman primates and other mammalian hosts of E. coli (13, 35). In
addition to isolates recovered from human patients with lower urinary
tract infections (cystitis) (25, 35, 36) and upper urinary tract infections
(pyelonephritis)(35,37),thiscollectionincludedsamplestakenfromtwo
additional patient populations. The compromised host anatomy group
included strains from patients with abnormal urinary tract anatomy, due
either to a congenital defect leading to clinical problems like vesi-
coureteral reﬂux (39), or to extrinsic factors such as the presence of an
indwelling Foley catheter (38). This patient group is at an increased risk
for UTIs from a variety of opportunistic pathogens (5). Finally, the col-
lection also included samples taken from patients with 105 CFU/ml of
urine,butwithoutsymptomsofcystitis(6),aconditionknownasasymp-
tomatic bacteriuria. Frozen glycerol stocks were streaked onto LB agar
plates and cultured aerobically at 37°C overnight for PCR testing.
Hemolysin phenotype. Blood agar plates were prepared as described
previously (40). For determination of the presence or absence of hemo-
lytic activity, a colony of each strain was streaked onto a blood agar plate
for isolation of single colonies and incubated overnight at 37°C. Plates
were examined the next day for a visible clearing surrounding isolated
single colonies. If no clearing was observed, part of a colony was pushed
aside with a sterile toothpick to look for clearing underneath the colony.
Any strain that showed clearing around or underneath isolated colonies
wasscoredaspositive,andallotherswerescoredasnegative.Strainswere
Vigil et al.
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between samples.
MultiplexPCR.PCRprimersweredesignedbasedonDNAsequences
foreachofthe15genesunderstudy.Eachgroupofsequenceswasaligned
and conserved regions of homology for each gene were chosen to create
primers that would generate PCR products of a unique length with a
100-bp difference in size from the other PCR products in the multiplex
assay.Twosetsofmultiplexprimerswerecreatedtomaximizetheamount
of difference in expected product size (Fig. 1A). Multiplex primer sets
were validated by amplifying puriﬁed genomic DNA from ﬁve sequenced
strains of E. coli (MG1655, HS, UTI89, 536, and CFT073) using DNeasy
columns (Qiagen). Multiplex PCRs used 1 l of DNA template, 12.5 l
multiplex PCR master mix (Qiagen), 1.25 l PCR primer mix (concen-
tration of stock, 2 pmol/l/primer), and 10.25 l nuclease-free water, for
a ﬁnal volume of 25 l. The thermal cycling protocol was (i) 95°C for
15min,(ii)94°Cfor0.5min,(iii)62°Cfor1.5min,(iv)72°Cfor1.5min,
(v) repeat steps ii to iv 29 times, and (vi) 72°C for 10 min. PCR products
wereseparatedbyelectrophoresison1.5%UltraPureagarose(Invitrogen)
Tris-actetate-EDTA(TAE)gels.Gelswerestainedwithethidiumbromide
and photographed under UV transillumination using a Gel Doc XR sys-
tem (Bio-Rad).
For multiplex screening, a single colony from each strain was scraped
from an LB agar plate with a sterile toothpick and resuspended in 50 l
sterile water. Cell suspensions were heated to 100°C for 10 min, cooled,
andfrozenuntiluse.PCRswerecarriedoutin25-lvolumesasdescribed
above, substituting 1 l of cell boil preparation for the DNA template.
Phylogenetictyping.ThemajorE.coliphylogeneticgroup(A,B1,B2,
and D) was determined by an established triplex PCR method (17), using
PCR reagents and cycling conditions as described above for virulence
genotyping.
MLST. Multilocus sequence typing (MLST) data were retrieved from
thedatabasemaintainedattheUniversityCollegeofCork(UCC)website
(http://mlst.ucc.ie)forthe72strainsoftheECORcollection.Theremain-
ing strains tested in the murine model of ascending UTIs were typed
accordingtostandardprotocols(18).Brieﬂy,genomicDNAwasextracted
from overnight cultures of each strain and used in separate PCRs with
primersforeachofthesevengenesusedinthedatabase(adk,fumC,gyrB,
icd, mdh, purA, and recA). PCR products were puriﬁed and submitted for
DNAsequencingusingthesameprimers.Dataforeachgenewerealigned
with reference sequences in the database and submitted to the online
analysis program at the UCC website for determination of the sequence
type for each strain.
Representative DNA sequences for the ECOR collection and the
strainsforwhichMLSTdataweregeneratedinthisstudywerealignedfor
each of the seven gene fragments in Lasergene 8 software (DNASTAR).
Alignments were imported to MEGA4 (41), and genes were aligned in
frame using in silico translation of codons. Using concatenated sequences
of the seven gene fragments, a neighbor-joining dendrogram was con-
structed in MEGA4 by the maximum composite likelihood method. An
E. coli clade I strain was used to root the dendrogram (42).
Murine model of ascending urinary tract infection. The murine
model of ascending UTI was followed as previously described (43).
Brieﬂy, female C57BL/6 mice, 4 to 6 weeks of age were transurethrally
inoculatedwith108CFUofthestrainofE.colibeingtested.Followingthis,
mice were allowed to recover and returned to the animal care facility.
Forty-eight hours postinoculation, animals were euthanized and bladder
and kidneys were aseptically removed, weighed, and placed into separate
test tubes ﬁlled with 3 ml of sterile PBS. Organs were homogenized, and
dilutions of the homogenate were plated onto LB agar plates with a Spiral
plater (Spiral Biotech) and incubated overnight at 37°C. The following
day, colony counts for each plate were enumerated, and the numbers of
CFU/g of tissue for each mouse were determined. If no colonies were
recovered, the sample was assigned a value of 100 CFU/g of tissue, the
limit of detection for this assay.
Statistical and data analysis. Images of agarose gels containing mul-
tiplex PCR products were scored for the presence or absence of each gene
under study for each strain. One-way ANOVA and Student’s t tests were
carried out using Prism software (GraphPad). Multivariate ANOVA test-
ing using the ANOSIM protocol was conducted using PRIMER version 6
(Primer-E).
Bayesian network analysis. The Bayesian network (BN) analysis was
performed using a web-based MARIMBA system (http://marimba
.hegroup.org/) (30). Investigators (Y.H. and A.P.H.) were blinded to the
putative roles of the 15 genes in virulence. Binary data (0 or 1) were
generatedforeachgene,representingthepresenceorabsenceofthisgene
for individual strains. A new variable called “group” was created to rep-
resent ﬁve different clinical settings for each strain: (i) fecal, (ii) compro-
mised host, (iii) ABU, (iv) cystitis, and (v) pyelonephritis. Simulated an-
nealing was used to search for candidate network structures where each
network has a unique set of connections between variables. In total, 750
million BNs were searched. A consensus network was calculated by con-
sidering the best 11 BN models sharing the top log posterior probability.
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